2020 was a massive year by any scale. We have gathered highlights here so you can easily find the research that will drive your next discovery. We present articles, chapters, highly cited journals and new books reflecting the year in Cell Biology and Biochemistry. You can browse this page, or dive more deeply into our individual imprints.
Search and browse by imprint
A selection of 2020's highlighted research
Journals
Journal Articles
Free to access until 31 March 2021, while open access articles are freely available online on a permanent basis.
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
from Nature
Authors: David E. Gordon et al.
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
from Cell Discovery
Authors: Yadi Zhou et al.
Mesenchymal stem cells as a potential therapy for COVID-19
from Stem Cell Research & Therapy
Authors: Shan Liu et al.
Protein assembly systems in natural and synthetic biology
from BMC Biology
Authors: Giulio Chiesa et al.
Bigdata analytics identifies metabolic inhibitors and promoters for productivity improvement and optimization of monoclonal antibody (mAb) production process
from Bioresources and Bioprocessing
Authors: Caitlin Morris et al.
Domesticated cynomolgus monkey embryonic stem cells allow the generation of neonatal interspecies chimeric pigs
from Protein & Cell
Authors: Rui Fu et al.
Top Journals
Books
Book Chapters
Free to access until 31 March 2021, while open access chapters are freely available online on a permanent basis.
NMR Lineshape Analysis of Intrinsically Disordered Protein Interactions
from Intrinsically Disordered Proteins
Authors: Christopher A. Waudby and John Christodoulou
Biotinylation of Membrane Proteins for Binder Selections
from Expression, Purification, and Structural Biology of Membrane Proteins
Authors: Benedikt T. Kuhn et al.
Overview of Immobilized Enzymes’ Applications in Pharmaceutical, Chemical, and Food Industry
from Immobilization of Enzymes and Cells
Authors: Alessandra Basso and Simona Serban
Serum Amyloid A (SAA) Proteins
from Vertebrate and Invertebrate Respiratory Proteins, Lipoproteins and other Body Fluid Proteins
Authors: George H. Sack
SUMO and Cytoplasmic RNA Viruses: From Enemies to Best Friends
from Proteostasis and Disease
Authors: Ahmed El Motiam et al.
Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
from Tumor Microenvironment
Authors: Matthew Dysthe and Robin Parihar
Connect with book editors in this area
Top new books in 2020
Insights from the Editorial Team
Bill Tucker, Vice President Books, Medicine & Life Sciences
The past year has seen the publication of numerous book chapters that are helping to understand the COVID-19 pandemic across all disciplines (starting from genomic sequencing to immune mechanisms to vaccine approaches right up to mainstream therapies). We have also taken important steps to develop a portfolio that is consistent with the Sustainable Development Goals of the United Nations. In the context of the crisis, we have maintained access to researchers and opened up our content as much as possible through various campaigns.
As we begin 2021, take a look back and reflect with a selection of the impactful work from over 60 research disciplines. Read and share the highly downloaded chapters for free until 31 March 2021. Open access content is freely available online on a permanent basis.
William Curtis, Executive Vice President Journals, Medicine & Life Sciences
The Medicine and Life Sciences journals portfolio includes more than 950 peer-reviewed journals covering all aspects of research from the bench to the bedside to the biosphere. Our objective is to create journals that lead their respective fields by focusing on attracting quality content, launching the right journals at the right time, and building strong partnerships with our external editors and societies. MLS journals are branded BMC, Springer, Springer Nature, and SpringerOpen and are available on the BMC.com, Nature.com and Springer.com platforms. We leverage the best of hybrid-subscription and open access business models - to become one better business and lead in the transition to Open Research in a sustainable way. To that end, more than one-third of MLS titles are fully open access. The MLS team of 150 colleagues is based in 15 SN locations around the world.
Publish with us
